Loading...
•
Dec 31, 2021
NextCure Q4 2021 Earnings Report
NextCure reported its Q4 2021 financial results and provided a business update.
Key Takeaways
NextCure reported its fourth quarter and full year 2021 financial results. The company's year-end cash position of $219.6 million is expected to fund operations into the first quarter of 2024.
NextCure set the stage for multiple data readouts in 2022.
Updates on NC318, NC410, and NC762 are expected in 2022.
The company's year-end cash position of $219.6 million is expected to fund operations into the first quarter of 2024.
The COVID-19 pandemic has impacted enrollment and operations at certain clinical trial sites, causing delays in some milestones.
NextCure
NextCure
Forward Guidance
NextCure expects its existing cash, cash equivalents and marketable securities will enable it to fund operating expenses and capital expenditures into the first quarter of 2024.